ArticleFrontiers in immunology

Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19.

Akash Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.